Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Delving into the details, we found 63% of traders were bullish, while 26% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $1,414,378, and 10 were calls, ...

Pacific Premier Bancorp (NASDAQ:PPBI) reported better-than-expected earnings for the third quarter of 2024, surpassing analyst expectations with an EPS of $0.37 against a forecast of $0.32. The ...

The Schwab U.S. Dividend Equity ETF offers automatic diversification, income, and growth. Read what makes SCHD a solid ...